Havens Advisors’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Havens Advisors’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,000	Closed	-$299K	–	53
2022 Q1	$299K	Hold	16,000	–	–	0.55%	31
2021 Q4	$342K	Buy	+16,000	New	+$315K	0.4%	27

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Havens Advisors's OCDX Position: Q2 2022 in Review

Havens Advisors sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 16,000 shares — an estimated $299K sold.

Havens Advisors first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $342K in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Havens Advisors reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Havens Advisors sold 16,000 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $299K.
Havens Advisors first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
Havens Advisors's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $342K in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Havens Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.